Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
Incidence and risk factors for pneumonitis due to trastuzumab Deruxtecan in metastatic breast cancer: a retrospective cohort study.
Journal: Breast cancer research : BCR
Published: May 07, 2025
Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Relapsed or Refractory Lymphoma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 10, 2025
Bronchoalveolar lavage cell percentages as diagnostic markers of immune checkpoint inhibitor pneumonitis.
Journal: Frontiers in medicine
Published: March 05, 2025
Long-Term Clinical, Radiological, and Mortality Outcomes Following Pneumonitis in Nonsmall Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Retrospective Analysis.
Journal: Clinical lung cancer
Published: April 26, 2024
Gravity- vs Wall Suction-Driven Large-Volume Thoracentesis: A Randomized Controlled Study.
Journal: Chest
Published: December 12, 2023
Heterogenous lung inflammation CT patterns distinguish pneumonia and immune checkpoint inhibitor pneumonitis and complement blood biomarkers in acute myeloid leukemia: proof of concept.
Journal: Frontiers in immunology
Published: June 28, 2023
Utility of Bronchoalveolar Lavage for the Diagnosis and Management of COVID-19 in Patients With Cancer.
Journal: The Journal of infectious diseases
Published: February 21, 2023
Pneumonitis After Concurrent Chemoradiation and Immune Checkpoint Inhibition in Patients with Locally Advanced Non-small Cell Lung Cancer.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: February 03, 2023
Incidence and Risk Factors for Pneumonitis Associated With Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer: A Single Center Experience.
Journal: The oncologist
Published: November 07, 2022
Last Updated: 09/26/2026